Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children

Area of Science:

• Pediatric critical care medicine
• Infectious disease management
• Clinical diagnostics

Background:

• Antibiotic stewardship is crucial in pediatric intensive care units (PICUs).
• Procalcitonin (PCT) is a biomarker used to guide antibiotic therapy.
• The impact of PCT availability on antibiotic prescribing patterns in PICUs requires further investigation.

Purpose of the Study:

• To evaluate the effect of introducing procalcitonin testing on antibiotic utilization.
• To assess changes in antibiotic initiation and duration in a pediatric intensive care unit setting.
• To determine if PCT availability alone influences antibiotic prescribing practices.

Main Methods:

• Retrospective study design.
• Analysis of antibiotic use data before and after procalcitonin assay introduction.
• Inclusion of patients from a large academic pediatric intensive care unit.
• Assessment of antibiotic initiation frequency and duration (>72 hours).

Main Results:

• Procalcitonin assay availability did not significantly reduce the frequency of antibiotic initiations.
• The duration of antibiotic therapy exceeding 72 hours was not decreased.
• No standardized algorithm for PCT use was implemented during the study period.

Conclusions:

• In the absence of a standardized protocol, procalcitonin availability alone did not improve antibiotic stewardship in this pediatric intensive care unit.
• Further research is needed to optimize the integration of PCT testing into clinical practice for effective antibiotic use reduction.
• Implementation strategies and clear guidelines are essential for leveraging PCT to guide antibiotic decisions in pediatric critical care.